Pang Jun (Jun Pang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Radical Prostatectomy

Endoplasmic Reticulum

Renal Cell Carcinoma

Top Venues

Cell death discovery

Cell death & disease

Biomaterials science

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mengjun Huang, Qiliang Teng, Fei Cao, Jinsheng Huang, Pang Jun
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomaterials science 12 (7) (2024)
Bing-Biao Lin, Qingqing Huang, Binyuan Yan, Mingcheng Liu, Zhiqian Zhang, Hanqi Lei, Ronghua Huang, Jin-Tang Dong, Pang Jun
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. British journal of cancer 131 (5) (2024)
Zhen Xu, Ze-Xiu Xiao, Jing Wang, Hao-Wei Qiu, Fei Cao, Shi-Qiang Zhang, Yuan-Dong Xu, Han-Qi Lei, Heng Xia, Yun-Ru He, Gao-Feng Zha, Pang Jun
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity. Oncoimmunology 13 (1) (2024)
Jun Li, Qian Zhang, Yupeng Guan, Dingzhun Liao, Huikun Chen, Haiyun Xiong, Yiyu Sheng, Xianju Chen, Pang Jun
TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2. Cell death & disease 15 (4) (2024)
Cao Fei, Xu Zhen, Shiqiang Zhang, Pang Jun
Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma. Cell death discovery 10 (1) (2024)
Hao Zhang, Chengyuan Xing, Binyuan Yan, Hanqi Lei, Yupeng Guan, Shiqiang Zhang, Yang Kang, Pang Jun
Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy. Biomacromolecules (2024)
Bing-Biao Lin, Qingqing Huang, Binyuan Yan, Mingcheng Liu, Zhiqian Zhang, Hanqi Lei, Ronghua Huang, Jin-Tang Dong, Pang Jun
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. British journal of cancer (2024)
Mengjun Huang, Qiliang Teng, Fei Cao, Jinsheng Huang, Pang Jun
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomaterials science (2024)
Jun Li, Qian Zhang, Yupeng Guan, Dingzhun Liao, Huikun Chen, Haiyun Xiong, Yiyu Sheng, Xianju Chen, Pang Jun
TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2. Cell death & disease 15 (4) (2024)
Bin Xu, Hanqi Lei, Tongyu Tong, Yupeng Guan, Yiyao Wang, Bo Li, Shiqiang Zhang, Chengyuan Xing, Xin-Tao Shuai, Jinsheng Huang, Pang Jun
Acidity-Actuated Polymer/Calcium Phosphate Hybrid Nanomotor (PCaPmotor) for Penetrating Drug Delivery and Synergistic Anticancer Immunotherapy. Nano letters (2024)
Cao Fei, Xu Zhen, Shiqiang Zhang, Pang Jun
Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma. Cell death discovery 10 (1) (2024)
Hao Zhang, Chengyuan Xing, Binyuan Yan, Hanqi Lei, Yupeng Guan, Shiqiang Zhang, Yang Kang, Pang Jun
Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy. Biomacromolecules 25 (6) (2024)
Mengjun Huang, Qiliang Teng, Fei Cao, Jinsheng Huang, Pang Jun
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer. Biomaterials science 12 (7) (2024)
Cao Fei, Xu Zhen, Shiqiang Zhang, Pang Jun
Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma. Cell death discovery 10 (1) (2024)
Jun Li, Qian Zhang, Yupeng Guan, Dingzhun Liao, Huikun Chen, Haiyun Xiong, Yiyu Sheng, Xianju Chen, Pang Jun
TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2. Cell death & disease 15 (4) (2024)
Cao Fei, Xu Zhen, Shiqiang Zhang, Pang Jun
Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma. Cell death discovery 10 (1) (2024)
Cao Fei, Xu Zhen, Shiqiang Zhang, Pang Jun
Frontier knowledge and future directions of programmed cell death in clear cell renal cell carcinoma. Cell death discovery 10 (1) (2024)
Zhen Xu, Ze-Xiu Xiao, Jing Wang, Hao-Wei Qiu, Fei Cao, Shi-Qiang Zhang, Yuan-Dong Xu, Han-Qi Lei, Heng Xia, Yun-Ru He, Gao-Feng Zha, Pang Jun
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity. Oncoimmunology 13 (1) (2024)
Yuandong Xu, Yuexiao Hu, Heng Xia, Shiqiang Zhang, Hanqi Lei, Binyuan Yan, Ze Xiu Xiao, Jinjin Chen, Pang Jun, Gao-Feng Zha
Delivery of Mrna Vaccine with 1, 2-diesters-derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy. Advanced healthcare materials (2023)
Rui Sun, Binyuan Yan, Hao Li, Dongling Ding, Liguo Wang, Pang Jun, Dingwei Ye, Zhenlin Huang
Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis. Cancer research (2023)
Tongyu Tong, Hanqi Lei, Shiqiang Zhang, Donggen Jiang, Yupeng Guan, Chengyuan Xing, Huikun Chen, Xiangwei Yang, Yang Kang, Pang Jun
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and Peroxidation. Advanced healthcare materials 11 (23) (2022)
Xiangwei Yang, Hong Chen, Duanya Xu, Xianju Chen, Yamei Li, Jun Tian, Dongwen Wang, Pang Jun
Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial. BMC cancer 22 (1) (2022)
Jun Li, Qian Zhang, Yupeng Guan, Dingzhun Liao, Donggen Jiang, Haiyun Xiong, Hengji Zhan, Pang Jun
Circular RNA circVAMP3 promotes aerobic glycolysis and proliferation by regulating LDHA in renal cell carcinoma. Cell death & disease 13 (5) (2022)
Yafei Yang, Donggen Jiang, Ziyu Zhou, Haiyun Xiong, Xiangwei Yang, Guoyu Peng, Wuchao Xia, Shang Wang, Hanqi Lei, Jing Zhao, Zhirong Qian, Song Wu, Pang Jun
CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer. Cellular oncology (Dordrecht) 44 (4) (2021)
Lujing Li, Tongyu Tong, Qiao Ji, Zuofeng Xu, Yupeng Guan, Xin Liang, Hai Huang, Yang Kang, Pang Jun
Dual pH- and Glutathione-Responsive CO2-Generating Nanodrug Delivery System for Contrast-Enhanced Ultrasonography and Therapy of Prostate Cancer. ACS applied materials & interfaces 13 (11) (2021)
Jun Li, Donggen Jiang, Qian Zhang, Shubin Peng, Guolong Liao, Xiangwei Yang, Jiani Tang, Haiyun Xiong, Pang Jun
MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma. Cancer management and research 12 (2020)
Yihang Pan, Meiqi Xin, Changhua Zhang, Willa Dong, Yuan Fang, Wenhui Wu, Mingzhe Li, Pang Jun, Zilong Zheng, Johnson Zixin Wang, Jin-Qiu Yuan, Yu-Long He
Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study. Journal of medical Internet research 22 (10) (2020)